Home Clinical Topics Medications

Medications

An overview of neuraxial anesthesia

Please visit the ANA’s website to take the CE: https://www.nursingworld.org/continuing-education/an-overview-of-neuraxial-anesthesia/ Understand the basics so you can effectively manage your patients. Takeaways: Neuraxial anesthesia is the administration of medication into the subarachnoid or epidural space to produce...

Cannabinoid hyperemesis syndrome explained

Learn how to identify this frequently misdiagnosed condition. Takeaways: Cannabinoid hyperemesis syndrome is a growing but poorly understood healthcare concern within the rising number of chronic, habitual cannabis users in the United States. Cannabinoid hyperemesis...

New treatment for multiple myeloma

The U.S. Food and Drug Administration (FDA) recently approved Sanofi-Aventis’ Sarclisa (isatuximab-irfc) for the treatment of  adult patients with multiple myeloma. Isatuximab-irfc was previously designated its orphan drug status by the FDA. Isatuximab-irfc was approved...

The changing face of cystic fibrosis

It’s no longer a childhood illness. Takeaways: The Cystic Fibrosis Foundation Patient Data Registry shows that more than 54% of people with cystic fibrosis live 18 years and beyond. Longer life expectancy is due to...

Avoiding antipsychotic medication use in nursing home residents with dementia

Nurses are critical to improved resident well-being. Takeaways: Elderly patients using antipsychotic medications are at a 1.6 to 1.7 times increased of risk of death, and antipsychotic medications are associated with significant side effects. Individual...

Study shows reduced risk of cardiovascular disease during times of bereavement with daily aspirin...

A study published in the American Heart Journal explored the effects of aspirin and low dose metoprolol intake during early bereavement periods. Times of bereavement are often associated with an “increased risk of cardiovascular disease,”...

New vaccine eliminated breast cancer in first human patient

A vaccine being developed in the Mayo Clinic in Jacksonville, Florida is aimed at preventing new cases of ovarian and breast cancer and even recurring cases of these cancers. The vaccine is currently being tested,...

New treatment for peanut allergy in children

The U.S. Food and Drug Administration (FDA) recently approved Aimmune Therapeutics’ Palforzia for children suffering from peanut allergy. Palforzia is intended to help “allergic reactions, including anaphylaxis, that may occur with accidental exposure...

Ultrasound-guided I.V. catheter insertion

Standardized protocols and education can improve patient safety, reduce costs, and enhance nursing practice. Takeaways: Achieving peripheral I.V. access can be difficult, even for experienced clinicians. Approximately 90% of hospitalized patients require some form of...

FDA launches mobile app on antiretrovirals

On Jan. 29, the FDA launched an interactive database that will offer a wealth of critical information about antiretrovirals eligible for purchase under the President’s Emergency Plan for AIDS Relief (PEPFAR) program. Read more https://www.fda.gov/news-events/press-announcements/fda-launches-mobile-friendly-database-information-life-saving-hiv-drugs-part-ongoing-mission-empower.

New treatment for advanced epithelioid sarcoma

The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with metastatic or advanced epithelioid sarcoma (AES). AES is a rare sarcoma that affects...

Survey reveals 40% of patients with MS stop taking medications because of cost

A new survey conducted by the National MS Society (NMSS) reveals that 40% of respondents “altered or stopped taking their medication” due to the medication(s) high costs. NMSS also highlights that in 2019, the...

First FDA approved treatment for thyroid eye disease

The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults with thyroid eye disease (TED). TED is a rare disorder which causes the...